Metabolites in Safety Testing (MIST): Analytical Strategy

In this webinar, Dr. Philip Tiller reviews Metabolites in Safety Testing (MIST) and discusses the scientific foundation of our analytical approach. Finally Dr. Tiller shares a case study of our success.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

Metabolites in Safety Testing (MIST): Analytical Strategy

Resources to Consider

Biologics Analytical Testing Services

GMP Analytical Testing in Gene Therapy Products

Outsourcing Analytical Testing For Biologics – A CRO’s...

CMC GMP Analytical Testing for New Chemical Entities and Commercial...

CMC GMP Analytical Testing for Biologics

Cell-Free DNA NGS Testing

Testing of Carryover & After MRD Benchtop Stability for...

Guidelines for Developmental and Reproductive Toxicity (DART) Testing

Tissue IHC: from R&D to Clinical Lab Testing

Microbiological Testing Considerations for Pharmaceutical Products

Stability Testing

Intraperitoneal Dose Administration: Successful Testing Using IP...